New Treatments and Tips for Dealing With Blood Cancer
New research in blood cancer includes new treatment options for acute myeloid leukemia and a novel therapy using BK virus-specific T cells to treat BK virus-associated hemorrhagic cystitis.
Becoming an Informed Patient With Rare Cancer
Dr. Gabriela Hobbs offers insight into a rare cancer, myeloproliferative neoplasms, to help patients learn more during their treatment journey.
The Power of the Immune System: New Treatment for Painful Blood Cancer Side Effect
A new T-cell therapy can be highly effective in treating BKV-associated hemorrhagic cystitis while minimizing side effects.
Better Days Ahead for Patients With AML
An abundance of clinical trials is giving patients with acute myeloid leukemia (AML) hope for a better future.
The Future of Cancer Looks Bright With Engineered Cells
Engineered cell technology is an example of ingenuity that brings together cutting-edge laboratory science and clinical trials to address aggressive cancers.
Paying It Forward for Other Patients With Multiple Myeloma
After receiving a diagnosis of multiple myeloma, a patient relied on the Multiple Myeloma Research Foundation for information and is becoming part of the conversation.
‘Promising Times’ for Patients With CLL
A fixed-duration treatment regimen may result in better outcomes and less time in the hospital for patients with CLL.
A New Line of Defense in Blood Cancer: Natural Killer Cell Therapy
Natural killer cell therapy is making strides in blood cancer research, but there’s still much more to learn.
It Takes a Village: Cancer Caregivers Need to Care for Themselves, Too
Caregivers of patients with cancer may face financial toxicity and stress — with little time to take care of themselves.
2 Clarke Drive Cranbury, NJ 08512